Free Shipping on Orders Over $500! Shop Now>>
Free Shipping on Orders Over $500! Shop Now>>
Cutting-edge diagnostic solution designed to rapidly and accurately detect and differentiate between SARS-CoV-2, influenza A, and influenza B antigens. This test is essential for healthcare professionals seeking efficient and reliable point-of-care testing to make informed decisions promptly.
Triple Detection in One Test:
Identifies SARS-CoV-2, Influenza A, and Influenza B in a single, efficient testing process.
Fast Results:
Get clear, reliable results within 10 minutes, enabling immediate clinical decisions.
High Sensitivity & Specificity:
Clinically validated for accuracy, with a sensitivity rate of 87.5% for COVID-19, 85.9% for Influenza A, and 86.8% for Influenza B.
Simple & Non-Invasive:
Uses gentle nasal swabs, making it more comfortable for patients while maintaining diagnostic reliability.
FDA Emergency Use Authorized (EUA):
Meets high regulatory standards, ensuring safety and effectiveness in clinical settings.
Cost-Effective Solution – Reduces the need for multiple tests, optimizing resources and saving time for healthcare providers.
The WELLlife COVID-19 & Influenza A/B Test is ideal for use in hospitals, urgent care centers, clinics, and other point-of-care locations. Its rapid turnaround time allows healthcare providers to accurately diagnose patients exhibiting flu-like symptoms and determine the best course of action for treatment and isolation.
Globalsupplyexchange.com is currently under maintenance. We appreciate your business and have temporarily redirected you to our alternative shop, where you can find the same products and enjoy the same quality service.
